Studies have indicated that the aberrant activation of PADI2, a gene expressed throughout the nervous system, is likely associated with the development of neuropsychiatric diseases characterized by neurodegenerative processes, such as Alzheimer's disease and multiple sclerosis (Watanabe et al., 2009). This evidence concerns the gene PADI2 and multiple sclerosis.